เปิดทำการกี่โมง?

จันทร์ 09:00 - 17:00 อังคาร 09:00 - 17:00 พุธ 09:00 - 17:00 พฤหัสบดี 09:00 - 17:00 ศุกร์ 09:00 - 17:00

เว็บไซต์คืออะไร?

https://www.facebook.com/105761429207269/

FloraTerra

Dedicating our lives to propagating the knowledge of this amazing plant medicine around the world.
(1)

10/05/2025

Previous Cannabis Use Myth Dispelled?

Once again the legalization and increased research into cannabis use in humans are dispelling previous beliefs. A 2025 paper outlining a study led by Boston University School of Public Health challenges previous assumptions about cannabis use and male fertility. The research analyzed semen samples from 921 men, focusing on metrics like s***m count, concentration, motility, and volume and showed no statistically significant differences were found between cannabis users and non-users in these measures, even among daily users (3.3% of participants) or regular users (22.6%) .

This finding contrasts with earlier studies that suggested cannabis might lower testosterone or s***m quality. The researchers noted inconsistencies in prior work, such as animal studies indicating THC (the psychoactive compound in cannabis) could affect testicular function, but these effects were not observed in their human cohort . They emphasized that while their results add valuable evidence, they do not conclusively resolve the debate.

The study highlights the need for further large-scale, long-term research across diverse populations to better understand cannabis's reproductive health impacts.

Source: https://www.sciencealert.com/does-cannabis-lower-s***m-quality-new-study-reveals-a-surprise-result

30/01/2025

New Yale University Study Shows Cannabis may be more Effective than Opioids

A study by Yale University scientists found that non-psychoactive cannabinoids—CBD, CBG, and CBN—can suppress pain by targeting a protein (Nav1.8 in sensory neurons that transmits pain signals to the brain. Using rodent models, researchers observed that these cannabinoids reduced pain signaling, with CBG proving the most effective.

The study suggests that cannabinoids could offer a safer alternative to opioid-based pain medications, which have contributed to the ongoing opioid crisis due to their addictive nature and overdose risks. Researchers are optimistic that cannabinoid-based therapies could help treat chronic pain conditions such as neuropathy, arthritis, and inflammation without the harmful effects of opioids.

Source: https://doi.org/10.1073/pnas.2416886122

22/11/2024

A long-term study investigated the connection between ma*****na use and cognitive changes associated with aging in a group of 5,162 Danish men over 44 years. Researchers measured participants’ IQs at an average age of 22 and again at 62. The findings revealed that men who had used cannabis experienced less cognitive decline over time compared to those who had not.

On average, participants’ IQs dropped by 6.2 points during the study. However, cannabis users showed a smaller decline—1.3 points less than non-users—even after accounting for factors that could influence the results. Additionally, the study found no evidence that starting cannabis use earlier or using it frequently negatively impacted cognitive decline.

The researchers stated, “Men with a history of cannabis use had less cognitive decline from early adulthood to late midlife compared to men without a history of cannabis use.” They emphasized that neither the age at which cannabis use began nor its frequency significantly influenced cognitive changes over time.

The authors concluded that their findings are consistent with most existing studies, which generally show no strong link between ma*****na use and long-term cognitive decline. However, they called for more research to determine whether cannabis has no lasting negative effects on the brain or if any effects are temporary and fade with time.

This research challenges longstanding claims that ma*****na use harms IQ or cognitive function over time. Earlier studies linking cannabis to lower IQ have faced criticism for flawed methods, such as ignoring socioeconomic factors. For instance, a widely cited 2012 study suggesting early cannabis use caused lower IQ in midlife was later discredited for methodological issues.

Paul Armentano, Deputy Director of NORML, commented on the findings: “These results contradict one of the more prominent and longstanding stereotypes about cannabis and cannabis consumers. It is unfortunate that studies refuting these stereotypes rarely receive the attention they deserve.”

Other studies have similarly failed to find strong evidence of long-term cognitive harm from cannabis. For example, a 2024 review in JAMA Psychiatry reported that while cannabis use might cause short-term cognitive impairments, these effects typically disappear after 72 hours of abstinence.

Reference: https://thema*****naherald.com/2024/11/study-cannabis-use-associated-with-less-cognitive-decline-over-lifetime/

09/06/2024

Is there clinical evidence that Cannabinol (CBN) actually helps with sleep?

A study published in “Experimental and Clinical Psychopharmacology” investigated the effects of cannabinol (CBN) on sleep quality. Conducted by researchers at Canopy Growth Corporation, this Phase 2, randomized, double-blind, placebo-controlled trial involved 321 participants who reported poor sleep quality. The study found that a 20 mg dose of CBN reduced nighttime awakenings and overall sleep disturbances compared to a placebo, although it did not significantly improve overall sleep quality or reduce daytime fatigue. Combining CBN with cannabidiol (CBD) did not enhance sleep benefits. The study suggests CBN might help with sleep disturbances but emphasizes the need for further research on optimal dosages, long-term effects, and objective sleep measures.

To read the study in full, you can visit: https://psycnet.apa.org/fulltext/2024-14146-001.html

04/06/2024

Our first batch of craft grown cannabis is ready! Purple green and densely frosted. Grapey, candy, creamy smooth! 🍭🍇🔥💚♥️💜 Now Available for pickup. Get it direct from the licensed farm. All order sizes welcome. Tasting and sample orders welcome.

30/05/2024

Americans Prefer Buds Over Booze: A Shift in Consumption Trends

A recent consumer market report released by Carnegie Mellon University reveals that daily or near-daily ma*****na use in the U.S. now surpasses similar levels of alcohol consumption. Examining 40 years of data from over 1.6 million participants across 27 surveys (1979-2022), the study shows that in 2022, 17.7 million Americans reported daily cannabis use compared to 14.7 million daily drinkers. This marks a significant increase from 1992 when only 900,000 Americans used ma*****na daily.

The growing acceptance of cannabis, especially among younger generations, is driving this shift. The report highlights that younger demographics are increasingly substituting alcohol and to***co with cannabis. This trend is expected to continue as legal cannabis options become more prevalent.

The cannabis industry's anticipation of eased federal restrictions by the DEA could further boost its growth, providing greater access to funding, research, and investment opportunities. Companies like Tilray, Canopy Growth, and Curaleaf stand to benefit.

Meanwhile, the alcohol industry is grappling with these changing preferences. Younger legal drinking-age consumers are drinking less, partly due to increased cannabis use and the availability of quality non-alcoholic options. Analysts predict that the legal cannabis market could significantly impact alcohol sales, though state-by-state policies currently mitigate the effect.

Overall, the landscape of American substance use is evolving, with cannabis poised to play a more dominant role in the future.

The entire landscape of cannabis is changing rapidly around the world. For more information on how FloraTerra can help your company in the medical cannabis space, please reach out to us for a free consultation.

Source: https://www.heinz.cmu.edu/media/2024/May/new-study-highlights-significant-increases-in-cannabis-use-in-united-states

25/04/2024

New Research Identifies Cannabis Compound That May Counteract Anxiety

Recent research published in Drug and Alcohol Dependence highlights the potential of a naturally occurring compound in cannabis, d-limonene, to alleviate anxiety-inducing effects associated with THC consumption. While cannabis is known for its relaxing properties, excessive intake can lead to acute anxiety, commonly referred to as "paranoia." The study suggests that strains high in d-limonene could help users avoid such reactions, enhancing the therapeutic benefits of ma*****na.

The entourage effect, a concept suggesting synergy among cannabis compounds, has intrigued researchers and enthusiasts for years. Although lacking clear scientific evidence, this idea has influenced the breeding and marketing of cannabis strains. Building on previous findings indicating d-limonene's anxiety-reducing properties, researchers conducted a controlled study led by Ryan Vandrey from Johns Hopkins University.

The study involved participants who experienced anxiety from cannabis in the past. Through vaporized inhalation, researchers tested various combinations of THC and d-limonene concentrations. Results showed a correlation between increased d-limonene levels and reduced anxiety symptoms, particularly at high ratios compared to THC.

While the study sheds light on the potential of d-limonene, it also highlights the need for further research on cannabis compounds and their interactions. Scientists caution against solely relying on this research for consumer decisions, emphasizing the importance of comprehensive studies to understand the benefits and risks of cannabis.

Future investigations aim to explore the effects of other terpenes found in cannabis, contributing to a better understanding of how these compounds influence cannabis experiences. Moreover, historical remedies, such as consuming citrus fruits to counteract cannabis-induced effects, underscore the longstanding interest in mitigating adverse reactions associated with ma*****na consumption.

Source: https://www.scientificamerican.com/article/lemon-scented-ma*****na-compound-reduces-weeds-paranoia-effect/

26/02/2024

Lots of clones!!

20/01/2024

Medical Cannabis May Help Patients Suffering from Chronic Depression

A recent study published in the peer-reviewed journal Pharmacopsychiatry of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP) suggests that medical cannabis may offer sustainable improvement for chronic depression. The 18-week study involving 59 patients who had unsuccessfully tried traditional medications showed statistically significant improvement in depression severity. Despite mild side effects in some patients, the research supports the safety and efficacy of medical cannabis treatment for patients suffering from chronic depression. The study's authors recommend further investigation through larger prospective cohort studies and randomized trials to provide further evidence of the safety and efficacy of medical cannabis treatment. To read the full details of the study, please see the reference below.

Reference:
Specka M, Bonnet U, Schmidberg L, Wichmann J, Keller M, Scholze C, Scherbaum N. Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study. Pharmacopsychiatry. 2024 Jan 11. doi: 10.1055/a-2215-6114. Epub ahead of print. PMID: 38211630.

15/01/2024

Lifetime of Cannabis Use Does Not Have Significant Social or Psychological Effect

A recently published study in Journal of Psychopathology and Clinical Science concluded after a 30-year community study of 4,078 American twins, when participants compared to their respective co-twin in the study, lifetime cannabis use has “few persistent effects on mental health and other psychosocial outcomes. The notable exceptions are cannabis use disorder, to***co frequency, and illicit drug use, for which lifetime cannabis frequency causes small increases.”

The information provided in medical study is for informational purposes only and should not be considered as medical advice. Always consult with a qualified healthcare professional for personalized guidance regarding your health and medical conditions.

References:

Zellers, S., Alexander, J., Ellingson, J. M., Schaefer, J. D., Corley, R. P., Iacono, W., Hewitt, J. K., Hopfer, C. J., McGue, M. K., & Vrieze, S. (2024). Limited psychological and social effects of lifetime cannabis use frequency: Evidence from a 30-year community study of 4,078 twins. Journal of Psychopathology and Clinical Science, 133(1), 115–128. https://doi.org/10.1037/abn0000867

08/01/2024

Preclinical Trials Show Neuroprotective Wffects of CBD on Alzheimer’s Patients

A recent study published in Cells suggests that Cannabidiol (CBD) exhibits neuroprotective effects against neurodegeneration associated with Alzheimer's disease (AD). The research found that CBD countered the cytotoxicity of amyloid beta plaques in cell models and ameliorated cognitive impairments in mouse models. Additionally, CBD restored synaptic proteins, neurotrophic factors, and modulated inflammatory pathways, supporting its potential in preventing or mitigating the effects of AD. The authors propose that future CBD formulations might include indications for AD prevention and alleviation.

References:

Chen L, Sun Y, Li J, et al. Assessing cannabidiol as a therapeutic agent for preventing and alleviating Alzheimer’s disease neurodegeneration. Cells. 2023;12(23):2672. doi:10.3390/cells12232672

Source: Forbes.com

24/12/2023

Happy Holidays from the FloraTerra Family!

ที่อยู่

Amphoe Bang Lamung

เวลาทำการ

จันทร์	09:00 - 17:00
อังคาร	09:00 - 17:00
พุธ	09:00 - 17:00
พฤหัสบดี	09:00 - 17:00
ศุกร์	09:00 - 17:00

เบอร์โทรศัพท์

+66838087555

เว็บไซต์

facebook.com

แจ้งเตือน

รับทราบข่าวสารและโปรโมชั่นของ FloraTerraผ่านทางอีเมล์ของคุณ เราจะเก็บข้อมูลของคุณเป็นความลับ คุณสามารถกดยกเลิกการติดตามได้ตลอดเวลา

ติดต่อ การปฏิบัติ

ส่งข้อความของคุณถึง FloraTerra:

ชื่อ:

ที่อยู่อีเมล์:

ข้อความ:

ทางลัด

ที่อยู่
เบอร์โทรศัพท์
เวลาทำการ
แจ้งเตือน
ติดต่อ การปฏิบัติ
อ้างสิทธิ์หรือรายงานรายการ

ต้องการให้ธุรกิจของคุณ การปฏิบัติ ขึ้นเป็นอันดับหนึ่ง คลินิก ใน Amphoe Bang Lamung?